Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Lymphoma 53Lymphoma, Non-Hodgkin 36Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Follicular 28Lymphoma, Mantle-Cell 26Glioblastoma 25Central Nervous System Neoplasms 25Hodgkin Disease 22Gliosarcoma 21Astrocytoma 21Lymphoma, Large-Cell, Immunoblastic 20Brain Neoplasms 20Burkitt Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Multiple Myeloma 15Glioma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Oligodendroglioma 12Lymphoma, B-Cell, Marginal Zone 11Leukemia 10Neoplasms, Plasma Cell 9Recurrence 7Lymphoma, B-Cell 5Waldenstrom Macroglobulinemia 4Medulloblastoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Leukemia, Myeloid, Acute 4Ependymoma 4Lymphoma, Large-Cell, Anaplastic 3

Interventions

Temozolomide 6Cyclophosphamide 4antineoplaston AS 2-1 3antineoplaston A10 3Radiotherapy 3Filgrastim 3sargramostim 2aldesleukin 2Vincristine 2Thalidomide 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Irinotecan 2Donepezil 2Cisplatin 2Carmustine 2Bevacizumab 2veliparib 1trametinib 1temsirolimus 1surufatinib 1spartalizumab 1sonidegib 1ribociclib 1reolysin 1plerixafor 1ganitumab 1fosbretabulin 1entinostat 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors, Primitive × Carmustine × Clear all
NCT00014573 2013-04-08

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

NCT00004028 2009-02-09

Carmustine in Treating Patients With Recurrent Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡